<DOC>
	<DOCNO>NCT02185274</DOCNO>
	<brief_summary>Gender identity disorder ( also know transsexualism ) define condition person apparently normal somatic sexual differentiation convince actually member sex . Most patient therefore undergo call cross-sex hormone treatment . Treatment protocols follow international consensus statement vary considerably different centre country since prospective control trial available subject recommendation mainly base retrospective data analysis experience individual centre . Applying high dos testosterone biological female vice versa high dos estradiol biological male definitely impact myriad body function , assumed minority already elucidate far . Especially male-to-female-transsexuals seem increase risk development mood disorder cardiometabolic comorbidities . In multi-center observational study want investigate , difference regard outcome , accord varying standard cross-sex hormone treatment different center . Different outcome measure describe assessed time routine visit different center .</brief_summary>
	<brief_title>Observational Study Metabolism Psychopathology Transsexual Patients</brief_title>
	<detailed_description />
	<mesh_term>Transsexualism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Inclusion criterion Patients diagnosis gender identity disorder ( ICD10 : F64.0 ) , give write informed consent follow adequate oral write information . General Exclusion criterion Patients age 18 Legally incompetent patient Prior intake crosssex hormone Missing write informed consent Intersexuality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Transsexualism</keyword>
	<keyword>Cross-sex hormone treatment</keyword>
	<keyword>Sex hormone</keyword>
	<keyword>Mood</keyword>
	<keyword>Stress</keyword>
	<keyword>Cortisol</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Metabolome</keyword>
</DOC>